The ERA-NET NEURON partner countries are issuing the EXCELLENT PAPER IN NEUROSCIENCE AWARD to recognize the remarkable and outstanding scientific publications by early-career researchers in the field of disease-related, translational, neurosciences. Sole First author of original research articles published between January 1, 2021, and December 31, 2021 and affiliated with the call partner countries listed below are eligible to apply. 

Call Partner Countries (23): Belgium, Canada, Croatia, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Norway, Poland, Portugal, Romania, Slovakia, Spain, Switzerland, Taiwan, Turkey, United Kingdom.

The Excellent Paper in Neuroscience Award 2022 focuses on Sensory Disorders. The article should contribute progress on important questions related to sensory disorders of neural origin and their impact on the nervous system, including all the sensory modalities as well as multisensory dysfunctionc diseases.

Author:

• The sole first Author in the proposed publication. Shared first authorships are not considered for the award.
• The Author must have been affiliated with a call partner country at the time of publication (list of eligible countries above).
• Pre- doctoral and postdoctoral early career researchers until a maximum of three years from a PhD or an equivalent degree at the date of publication.
• Eligible breaks include parental leaves, long-term illness, and national service. Concerning parental leave, national rules apply, or 12 months per child, whichever is the greatest.
• A minimum formation in research (M.Sc. or Ph.D.) is required.

Publication:

• Award period: published between January 1, 2021 and December 31, 2021.
• Affiliation of the sole first Author with a call partner country as stated in the publication.
• Article published in open access or available via open access publication repository is encouraged.
• Original research article published in an international peer review journal.
• Topic of the article must be clearly relevant to disease-related, translational, neurosciences and it must fall into one of the following two categories:
  • Fundamental research addressing the pathogenesis and etiology of sensory disorders. This may include the development of innovative or shared resources and technologies. The relevance of the research to sensory systems disorders must be clearly described.
  • Clinical research to develop novel strategies for prevention, diagnosis, patient stratification, therapy and/or rehabilitation for sensory disorders.

In case of interest please click on "m'interessa"  and we will contact you.